Search Results

There are 12709 results for: content related to: Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus

  1. Lamivudine salts with improved solubilities

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 6, June 2012, Pages: 2143–2154, Felipe T. Martins, Rudy Bonfilio, Magali B. De Araújo and Javier Ellena

    Version of Record online : 14 MAR 2012, DOI: 10.1002/jps.23117

  2. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  3. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  4. You have free access to this content
    Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy

    Hepatology

    Volume 34, Issue 4, October 2001, Pages: 785–791, Man-Fung Yuen, Erwin Sablon, Prof. Chee-Kin Hui, He-Jun Yuan, Hilde Decraemer and Ching-Lung Lai

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2001.27563

  5. Viral Hepatitis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Mario Rizzetto, Fabien Zoulim, Pages: 819–956, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch9a

  6. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22644

  7. Lamivudine/Zidovudine as a Combined Formulation Tablet: Bioequivalence Compared with Lamivudine and Zidovudine Administered Concurrently and the Effect of Food on Absorption

    The Journal of Clinical Pharmacology

    Volume 39, Issue 6, June 1999, Pages: 593–605, Dr. Katy H. P. Moore, Ms. Shuching Shaw, Dr. Aziz L. Laurent, Ms. Peggy Lloyd, Mr. Benjamin Duncan, Mr. David M. Morris, Mr. Michael J. O'Mara and Dr. Gary E. Pakes

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912709922008209

  8. You have free access to this content
    Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e Antigen–negative patients receiving lamivudine therapy

    Hepatology

    Volume 32, Issue 5, November 2000, Pages: 1145–1153, Anna Suk-Fong Lok, Munira Hussain, Carmela Cursano, Marzia Margotti, Annagiulia Gramenzi, Gian Luca Grazi, Elio Jovine, Mauro Benardi and Pietro Andreone

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2000.19622

  9. Tenofovir for the Treatment of Hepatitis B Virus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 10, October 2009, Pages: 1212–1227, Dr. Alice M. Jenh, Dr. Chloe L. Thio and Dr. Paul A. Pham

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.10.1212

  10. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Version of Record online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  11. Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 892–898, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki and Hiromitsu Kumada

    Version of Record online : 30 OCT 2009, DOI: 10.1111/j.1440-1746.2009.06161.x

  12. APASL Abstracts, Bali 2005

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1270–1384,

    Version of Record online : 11 NOV 2005, DOI: 10.1111/j.1478-3231.2005.01182.x

  13. Management of chronic hepatitis B virus infection: a new era of disease control

    Internal Medicine Journal

    Volume 36, Issue 2, February 2006, Pages: 100–113, G. C. Farrell and N. C. Teoh

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1445-5994.2006.01027.x

  14. You have free access to this content
    Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?

    Transplant International

    Volume 24, Issue 6, June 2011, Pages: 570–581, Guy N. Brock, Farida Mostajabi, Nicole Ferguson, Christopher J. Carrubba, Mary Eng, Joseph F. Buell and Michael R. Marvin

    Version of Record online : 15 MAR 2011, DOI: 10.1111/j.1432-2277.2011.01236.x

  15. You have free access to this content
    Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy

    Hepatology

    Volume 31, Issue 6, June 2000, Pages: 1318–1326, Chau-Ting Yeh, Rong-Nan Chien, Chia-Ming Chu and Yun-Fan Liaw

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2000.7296

  16. Abacavir/Lamivudine/Zidovudme As a Combined Formulation Tablet: Bioequivalence Compared with Each Component Administered Concurrently and the Effect of Food on Absorption

    The Journal of Clinical Pharmacology

    Volume 41, Issue 3, March 2001, Pages: 277–288, Dr. Geoffrey J. Yuen, Dr. Yu Lou, Dr. Nancy F. Thompson, Ms. Victoria R. Otto, Mr. Thurman L. Allsup, Mr. William B. Mahony and Dr. H. Wayne Hutman

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700122010096

  17. Lamivudine treatment of chronic hepatitis B

    Reviews in Medical Virology

    Volume 8, Issue 3, July/September 1998, Pages: 153–159, Geoffrey Dusheiko

    Version of Record online : 4 MAY 1999, DOI: 10.1002/(SICI)1099-1654(199807/09)8:3<153::AID-RMV228>3.0.CO;2-Y

  18. You have free access to this content
    Combination of HBIG and lamivudine-resistant mutations: A formula for trouble?

    Liver Transplantation

    Volume 8, Issue 11, November 2002, Pages: 1082–1084, Robert J. Fontana and Anna S.F. Lok

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jlts.2002.36238

  19. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Version of Record online : 27 DEC 2007, DOI: 10.1002/hep.22106

  20. Developmental Pharmacokinetic Changes of Lamivudine in Infants and Children

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1824–1832, Dr Adriana H. Tremoulet, Dr Mina Nikanjam, Dr Tim R. Cressey, Dr Kulkanya Chokephaibulkit, Dr Ross McKinney, Dr Mark Mirochnick and Dr Edmund V. Capparelli

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011426563